<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <title>IBS: Primary Care Quick Reference Algorithm</title>
  <style>
    :root{
      --bg:#f7f8fb;
      --surface:#ffffff;
      --ink:#1f2937;          /* slate-800 */
      --muted:#6b7280;         /* slate-500 */
      --accent:#2563eb;        /* blue-600 */
      --accent-2:#e0e7ff;      /* indigo-100 */
      --card:#ffffff;
      --good:#047857;          /* emerald-700 */
      --warn:#b45309;          /* amber-700 */
      --danger:#b91c1c;        /* red-700 */
      --pill:#eef2ff;          /* indigo-50 */
      --shadow: 0 10px 24px rgba(31,41,55,.08), 0 2px 8px rgba(31,41,55,.06);
    }
    html,body{height:100%}
    html{scroll-behavior:smooth}
    body{
      margin:0;
      font-family: ui-sans-serif, system-ui, -apple-system, Segoe UI, Roboto, Helvetica, Arial, "Apple Color Emoji", "Segoe UI Emoji";
      color:var(--ink);
      background:linear-gradient(180deg,#fbfdff, var(--bg));
    }
    /* Layout */
    .wrap{max-width:1200px; margin:0 auto; padding:28px 20px 56px}
    header.hero{display:flex; align-items:center; gap:24px; padding:24px; background:var(--surface); border-radius:20px; box-shadow:var(--shadow)}
    .emblem{min-width:64px; min-height:64px; border-radius:18px; background:linear-gradient(160deg,#93c5fd,#c7d2fe); display:grid; place-items:center}
    .emblem svg{width:36px; height:36px; opacity:.9}
    h1{margin:.1rem 0 .2rem; font-size:clamp(1.6rem,2.4vw,2.3rem); letter-spacing:.3px}
    p.subtitle{margin:.2rem 0 0; color:var(--muted)}

    .toolbar{display:flex; flex-wrap:wrap; gap:12px; margin:18px 0 0}
    .btn{appearance:none; border:0; background:var(--accent); color:white; padding:10px 14px; border-radius:12px; font-weight:600; cursor:pointer; box-shadow:0 2px 0 rgba(0,0,0,.06)}
    .btn.secondary{background:#eef2ff; color:#4338ca}
    .btn.ghost{background:#f3f4f6; color:#374151}

    /* Grid */
    .grid{display:grid; grid-template-columns: 280px 1fr; gap:22px; margin-top:22px}
    @media (max-width: 980px){ .grid{grid-template-columns:1fr} }

    /* Sidebar */
    .side{position:sticky; top:16px; align-self:start; background:var(--surface); border-radius:18px; box-shadow:var(--shadow); padding:16px}
    .side h3{margin:4px 0 10px; font-size:1rem}
    .nav{display:grid; gap:6px}
    .nav a{display:block; padding:10px 12px; border-radius:10px; text-decoration:none; color:#414a5a; background:var(--pill)}
    .nav a:hover{background:var(--accent-2)}

    /* Content */
    section.card{background:var(--card); border-radius:18px; box-shadow:var(--shadow); padding:22px; margin-bottom:18px}
    section.card h2{margin:0 0 10px; font-size:1.25rem}
    section.card p, section.card li{line-height:1.6}

    /* “Flow” list styling */
    .flow{display:grid; gap:14px}
    .step{border:1px solid #e5e7eb; border-left:6px solid var(--accent); padding:14px 16px; border-radius:14px}
    .step .kicker{font-size:.8rem; font-weight:700; letter-spacing:.06em; color:#334155; text-transform:uppercase}
    .badges{display:flex; flex-wrap:wrap; gap:8px; margin-top:8px}
    .badge{font-size:.78rem; padding:6px 10px; border-radius:999px; background:#eff6ff; color:#1e40af; border:1px solid #dbeafe}

    /* Columns */
    .cols{display:grid; gap:14px; grid-template-columns: repeat(3, 1fr)}
    @media (max-width: 900px){ .cols{grid-template-columns:1fr} }

    /* Inline callouts */
    .callout{display:flex; align-items:flex-start; gap:12px; padding:12px 14px; background:#f8fafc; border:1px solid #e5e7eb; border-radius:12px}
    .callout.good{border-left:6px solid var(--good)}
    .callout.warn{border-left:6px solid var(--warn)}
    .callout.danger{border-left:6px solid var(--danger)}

    ul.clean{margin:10px 0 0; padding-left:20px}

    footer{margin-top:18px; color:var(--muted); font-size:.9rem; text-align:center}

    /* Print styles: compact + hide controls */
    @media print{
      body{background:white}
      header.hero, .side, .btn, .toolbar{box-shadow:none}
      .toolbar{display:none}
      .grid{grid-template-columns:1fr}
      .wrap{padding:0}
      section.card{break-inside:avoid}
    }
  </style>
</head>
<body>
  <div class="wrap">
    <header class="hero">
      <div class="emblem" aria-hidden="true">
        <!-- Stethoscope icon -->
        <svg viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="1.6" stroke-linecap="round" stroke-linejoin="round">
          <path d="M6 3v5a6 6 0 0 0 12 0V3"/>
          <path d="M6 8a6 6 0 0 0 12 0"/>
          <path d="M12 17v3a3 3 0 0 0 6 0v-4"/>
          <circle cx="19" cy="10" r="2"/>
        </svg>
      </div>
      <div>
        <h1>IBS: Primary Care Quick Reference Algorithm</h1>
        <p class="subtitle">Clean, fast, and consultation‑ready. Light theme, print‑friendly.</p>
        <div class="toolbar">
          <button class="btn" onclick="window.print()">Print / Save PDF</button>
          <a href="#suspect" class="btn secondary">Jump to Algorithm</a>
          <a href="#drugs" class="btn ghost">Drug Summary</a>
        </div>
      </div>
    </header>

    <div class="grid" role="presentation">
      <aside class="side" aria-label="Quick navigation">
        <h3>Quick Nav</h3>
        <nav class="nav">
          <a href="#suspect">1 · Suspect IBS</a>
          <a href="#workup">2 · Initial Workup</a>
          <a href="#diagnose">3 · Positive Diagnosis</a>
          <a href="#firstline">4 · First‑line Management</a>
          <a href="#diet">5 · Dietitian / Low FODMAP</a>
          <a href="#drugs">6 · Drug Therapy</a>
          <a href="#refractory">7 · Refractory / Referral</a>
          <a href="#follow">Follow‑up</a>
        </nav>
      </aside>

      <main>
        <!-- Algorithm -->
        <section id="suspect" class="card">
          <h2>1) Suspect IBS (≥ 6 months, no red flags)</h2>
          <div class="flow">
            <div class="step">
              <div class="kicker">Typical features</div>
              <ul class="clean">
                <li>Abdominal pain/discomfort ± bloating</li>
                <li>Change in bowel habit (frequency or form)</li>
                <li>Related to defecation</li>
              </ul>
              <div class="badges">
                <span class="badge">Use Bristol Stool Scale</span>
                <span class="badge">Consider IBS‑D / IBS‑C / IBS‑M / IBS‑U</span>
              </div>
            </div>
            <div class="step">
              <div class="kicker">Alarm features → Urgent referral</div>
              <ul class="clean">
                <li>Unintentional weight loss, rectal bleeding, iron‑deficiency anaemia</li>
                <li>Age &gt; 60 with new change in bowel habit; positive FIT; raised faecal calprotectin</li>
                <li>Abdominal/rectal mass; persistent or frequent bloating in women &gt; 50</li>
                <li>Family history of bowel/ovarian cancer, coeliac disease, or IBD</li>
              </ul>
            </div>
          </div>
        </section>

        <section id="workup" class="card">
          <h2>2) Initial Workup</h2>
          <div class="cols">
            <div class="callout">
              <strong>History</strong>
              <ul class="clean">
                <li>Onset, duration, severity; stool description</li>
                <li>Diet, fibre intake; known triggers (caffeine, alcohol, spicy/fatty foods)</li>
                <li>Antibiotics, meds (incl. opioids); comorbidities; stress/anxiety/depression</li>
                <li>Impact on daily function; activity levels</li>
              </ul>
            </div>
            <div class="callout">
              <strong>Exam</strong>
              <ul class="clean">
                <li>Weight/BMI; assess for weight loss</li>
                <li>Abdominal palpation; consented rectal exam</li>
              </ul>
            </div>
            <div class="callout">
              <strong>Tests to exclude organic disease</strong>
              <ul class="clean">
                <li>FBC; ESR/CRP</li>
                <li>Coeliac serology</li>
                <li>Faecal calprotectin (esp. ≤45y with diarrhoea)</li>
              </ul>
            </div>
          </div>
        </section>

        <section id="diagnose" class="card">
          <h2>3) Make a Positive Diagnosis</h2>
          <div class="flow">
            <div class="step">
              <div class="kicker">Explain &amp; reassure</div>
              <ul class="clean">
                <li>Gut–brain axis; chronic, relapsing, benign</li>
                <li>Not linked to increased cancer or mortality</li>
                <li>Aim: symptom control &amp; quality of life (may not be complete relief)</li>
              </ul>
            </div>
          </div>
        </section>

        <section id="firstline" class="card">
          <h2>4) First‑line Management (all)</h2>
          <div class="cols">
            <div class="step">
              <div class="kicker">Lifestyle</div>
              <ul class="clean">
                <li>Regular meals; balanced diet; adequate fluids</li>
                <li>Physical activity ≥ 30 min moderate, 5 days/week</li>
                <li>Weight management if overweight/obese</li>
                <li>Address stress, anxiety, depression</li>
              </ul>
            </div>
            <div class="step">
              <div class="kicker">Dietary pointers</div>
              <ul class="clean">
                <li>Constipation → increase <em>soluble</em> fibre (e.g., ispaghula, oats, linseed)</li>
                <li>Diarrhoea/bloating → reduce insoluble fibre; limit caffeine, alcohol, fizzy drinks; avoid gas‑producing foods</li>
                <li>Probiotics: consider trial ≥ 12 weeks; stop if no benefit</li>
              </ul>
            </div>
            <div class="step">
              <div class="kicker">Review</div>
              <ul class="clean">
                <li>Plan review within 2 months; tailor next steps to symptoms</li>
              </ul>
            </div>
          </div>
        </section>

        <section id="diet" class="card">
          <h2>5) If Persistent Symptoms → Dietitian</h2>
          <div class="callout good">
            <div>
              <strong>Low FODMAP / Exclusion diet (time‑limited, supervised)</strong>
              <ul class="clean">
                <li>Reinforce general advice; consider single‑food avoidance</li>
                <li>Supervise to avoid nutritional gaps &amp; microbiome impact</li>
                <li>Re‑introduce FODMAPs per tolerance after restriction phase</li>
              </ul>
            </div>
          </div>
        </section>

        <section id="drugs" class="card">
          <h2>6) Drug Therapy (targeted; review at 3 months)</h2>
          <div class="cols">
            <div class="step">
              <div class="kicker">IBS‑C: Constipation</div>
              <ul class="clean">
                <li>Start bulk‑forming laxative; titrate to comfortable soft stool</li>
                <li><strong>Avoid lactulose</strong> (gas/bloating)</li>
                <li>Severe &amp; ≥12 mo refractory → <strong>Linaclotide 290&nbsp;mcg OD</strong>* (often secondary‑care initiation)</li>
              </ul>
            </div>
            <div class="step">
              <div class="kicker">IBS‑D: Diarrhoea</div>
              <ul class="clean">
                <li><strong>Loperamide</strong> PRN; titrate (usual 6–8 mg/day; max 16 mg/day)</li>
                <li>Counsel not to exceed dose or duration; rare cardiac risks with overdose</li>
              </ul>
            </div>
            <div class="step">
              <div class="kicker">Pain / Spasm</div>
              <ul class="clean">
                <li>Antispasmodics PRN: mebeverine, alverine, peppermint oil</li>
                <li>If ineffective → low‑dose <strong>TCA</strong> (e.g., amitriptyline 5–30 mg nocte, off‑label)</li>
                <li>If TCA not tolerated/ineffective → <strong>SSRI</strong> (citalopram, fluoxetine, sertraline, off‑label)</li>
              </ul>
            </div>
          </div>
          <p style="margin-top:8px; font-size:.9rem; color:var(--muted)">* Review linaclotide response at 4–12 weeks; stop if ineffective. Observe cautions (electrolytes/diarrhoea risk).</p>
          <div class="callout warn" style="margin-top:10px">
            <div>
              <strong>Safety snippets</strong>
              <ul class="clean">
                <li>Check contraindications in BNF/eMC (e.g., loperamide: avoid in UC flare, C. difficile, bacterial enterocolitis)</li>
                <li>Explain off‑label use for TCAs/SSRIs (pain modulation, GI effects)</li>
              </ul>
            </div>
          </div>
        </section>

        <section id="refractory" class="card">
          <h2>7) Refractory or Severe Symptoms</h2>
          <div class="flow">
            <div class="step">
              <div class="kicker">Re‑assess</div>
              <ul class="clean">
                <li>Recheck for alternative diagnoses / new red flags</li>
              </ul>
            </div>
            <div class="step">
              <div class="kicker">Refer</div>
              <ul class="clean">
                <li><strong>Gastroenterology</strong>: uncertainty, severe disease, refractory to optimal primary care, or patient request</li>
                <li><strong>Mental health</strong>: persistent ≥ 12 months and/or psychological comorbidity; consider CBT/psychological therapies earlier per availability/preferences</li>
              </ul>
            </div>
          </div>
        </section>

        <section id="follow" class="card">
          <h2>Follow‑up &amp; Review</h2>
          <ul class="clean">
            <li>Agree follow‑up with patient; initial review in 2–3 months</li>
            <li>Ongoing if on meds: every 6–12 months; adjust per response/tolerability</li>
          </ul>
        </section>

        <footer>
          <p>Designed for rapid consult use. Light theme • Responsive • Print‑ready.</p>
        </footer>
      </main>
    </div>
  </div>
</body>
</html>